GSK sells Ankleshwar unit to Glenmark
GlaxoSmithKline Pharmaceuticals Ltd has decided to sell its Ankleshwar bulk drug manufacturing unit to Mumbai-based Glenmark Pharmaceuticals Ltd for a consideration of Rs 14 crore.

‘Unethical practices prevail in vac market’
THE vaccine market in India has become dirty because of the unethical practices resorted to by the entrepreneurs, observes K Varaprasad Reddy, managing director of Shantha Biotechnics Private Ltd here.

GSK appoints new MD
GlaxoSmithKline International has announced the appointment of S Kalayanasundaram as the managing director of GlaxoSmithKline Pharmaceuticals Limited, India.

Corporate Scan
Why companies fail to sustain their success?
Companies should adopt strategies according to the present and future requirements of the market. This alone can enable them to among the topline, says R K Srivastava